All lobbying filings

LEWIS-BURKE ASSOCIATES, LLC

LEWIS-BURKE ASSOCIATES, LLC filed a Q3 report for DANAHER CORPORATION on October 14, 2026, reporting $36,000 in lobbying income.

Lobbying for DANAHER CORPORATION · For-profit Company - Biomedical Products

All filings by LEWIS-BURKE ASSOCIATES, LLC · Everything DANAHER CORPORATION has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 14, 2026

Income

$36,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 2

ANJALI HELENA TADAVARTHY

Previously held: Paid Intern - Washington DC Office of Senator Tina Smith
MICHAEL ANTHONY PETERSON

Previously held: Legislative Director, Sen. Leg. Assistant, Leg. Assistant, Leg. Correspondent/Digital Media Specialist, Staff Assistant, Intern, Congressman Peter J. Visclosky

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues pertaining to the regulation of cell and gene therapy products. Issues pertaining to the biomedical research enterprise.

Budget/Appropriations

H.R. 8646, FY 2027 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, Issues related to cell and gene therapy products at FDA.

Bills named in this filing 1

H.R. 8646
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.